Author:
Rutz H. P.,Mariotta M.,von Knebel Doeberitz M.,Mirimanoff R. O.
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology, Nuclear Medicine and imaging
Reference28 articles.
1. Aas T, Borensen A-L, Geisler S, et al. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 1996;2:811–4.
2. Brock WA, Williams M, McNancy D, Milas L, Peters LJ, Weichselbaum RR. Modification by dexamethasone of radiation response of in vitro cultured cells. Int J Radiat Oncol Biol Phys 1984;10:2113–7.
3. Chin KV, Ueda K, Pastan I, Gottesman MM. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 1992: 225:459–62.
4. Duggan DE, Yeh KC, Matalia N, Ditzler CA, McMahon FG. Bioavailability of oral dexamethasone. Clin Pharmacol Ther 1975;18:205–9.
5. Howley PM. Principles of carcinogenesis. In: DeVita VT, Hellmann S, Rosenberg SA, eds. Cancer: Principles and practice of oncology. 3rd edn. Philadelphia: J. B. Lippincott Co., 1993.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献